Feed/Companies/Boyi Group

Boyi Group

As of 10 Nov 2026, Boyi Group has raised $15.0M across 1 verified round on record (amounts in other currencies converted to USD); latest: nearly RMB 100 million Series B led by Changzhou High-End Functional Materials Industry Special Fund of Funds, Jiangsu Qingke Industrial Investment Development Group and 1 other, announced 4 Nov 2026.

BUILT ON

Visit site

Boyi Group specializes in the development and production of biological purification materials and associated services for the life sciences sector.

boyi-group.comChangzhou, Jiangsu, ChinaBiotechFounded 2022300 people

LATEST ROUND

Series B

$15.0M · 2026-11-04

RAISED ON RECORD · USD

$15.0M

across 1 verified round

INVESTORS

3 leads

SOURCES

from 2 publishers

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Rounds

[ 1 ]

Series BSeries B1 and B2

$15.0M · 2026-11-04

led by Changzhou High-End Functional Materials Industry Special Fund of Funds, Jiangsu Qingke Industrial Investment Development Group, Zero2IPO Industrial Investment

EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING

Series A · over RMB 100 million · 2023

led by Jinyu Maowu

Round	Amount	Announced	Lead	Buzz
Series B Series B1 and B2	$15.0M nearly RMB 100 million	2026-11-04	Changzhou High-End Functional Materials Industry Special Fund of Funds, Jiangsu Qingke Industrial Investment Development Group, Zero2IPO Industrial Investment	No recent discussion
2 sources · checked 6 times, last 2h ago [ VERIFIED · CORRECTED ] read against 2 sources Leads added Changzhou High-End Functional Materials Industry Special Fund of Funds, Zero2IPO Industrial Investment · longbridge.com Sources conflict on the lead, amount scope, and date; the B2-specific Source 1 determines the round amount, while Source 2's dated report determines the announcement date and combined financing total.

Company research

Fetched 6d ago

Boyi Group makes biological purification resins, in-vitro diagnostic raw materials, and life-science research reagents and instruments for biomedical customers.

Founders

Fang Li · founder and general manager
In 2013, after years of industry experience, he left a stable job and began the venture in Changzhou with two employees.

Business model

It makes money by selling biological purification resins, consumables and equipment, IVD microspheres and other diagnostic raw materials, and life-science reagents and instruments, while providing customized and overall technical solutions to biomedical customers.

Checked against 8 sources 6d ago

SOURCES

vcbeathealth.com/entity/253458 /article/63976

Boyi Group

Company

Rounds

Sources

Profile

Investors

Boyi Group

Rounds

Company research

Sources

Series B$15.0M2026-11-042 sources

Investors

Series B$15.0M2026-11-046 investors

EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING
Series A	over RMB 100 million	2023	Jinyu Maowu